Optimizing antithymocyte globulin dosing in haploidentical hematopoietic cell transplantation: long-term follow-up of a multicenter, randomized controlled trial.

MLA

Wang, Yu, et al. “Optimizing Antithymocyte Globulin Dosing in Haploidentical Hematopoietic Cell Transplantation: Long-Term Follow-up of a Multicenter, Randomized Controlled Trial.” Science Bulletin, vol. 66, no. 24, Dec. 2021, pp. 2498–505. EBSCOhost, https://doi.org/10.1016/j.scib.2021.06.002.

APA

Wang, Y., Liu, Q.-F., Lin, R., Yang, T., Xu, Y.-J., Mo, X.-D., & Huang, X.-J. (2021). Optimizing antithymocyte globulin dosing in haploidentical hematopoietic cell transplantation: long-term follow-up of a multicenter, randomized controlled trial. Science Bulletin, 66(24), 2498–2505. https://doi.org/10.1016/j.scib.2021.06.002

Chicago

Wang, Yu, Qi-Fa Liu, Ren Lin, Ting Yang, Ya-Jing Xu, Xiao-Dong Mo, and Xiao-Jun Huang. 2021. “Optimizing Antithymocyte Globulin Dosing in Haploidentical Hematopoietic Cell Transplantation: Long-Term Follow-up of a Multicenter, Randomized Controlled Trial.” Science Bulletin 66 (24): 2498–2505. doi:10.1016/j.scib.2021.06.002.